SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001513162-20-000009
Filing Date
2020-01-09
Accepted
2020-01-09 16:16:35
Documents
64
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 1624384
2 EXHIBIT 3.8 exhibit3_8.htm EX-3.8 119752
3 EXHIBIT 21 exhibit21.htm EX-21 12322
4 EXHIBIT 23.1 exhibit23_1.htm EX-23.1 2356
5 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 25113
6 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 23523
7 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 9121
8 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 9842
  Complete submission text file 0001513162-20-000009.txt   6319103

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT anix-20191031.xml EX-101.INS 1229336
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20191031.xsd EX-101.SCH 53883
11 XBRL TAXONOMY EXTENSION CALCULATIONS LINKBASE DOCUMENT anix-20191031_cal.xml EX-101.CAL 34818
12 XBRL TAXONOMY EXTENSION DEFINTIONS LINKBASE DOCUMENT anix-20191031_def.xml EX-101.DEF 301955
13 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anix-20191031_lab.xml EX-101.LAB 420937
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20191031_pre.xml EX-101.PRE 300488
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 20518352
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences